Cargando…
Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716918/ https://www.ncbi.nlm.nih.gov/pubmed/35584340 http://dx.doi.org/10.1164/rccm.202205-0835LE |
_version_ | 1784842792532443136 |
---|---|
author | Molyneaux, Philip L. Maher, Toby M. |
author_facet | Molyneaux, Philip L. Maher, Toby M. |
author_sort | Molyneaux, Philip L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9716918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Thoracic Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-97169182022-12-05 Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice Molyneaux, Philip L. Maher, Toby M. Am J Respir Crit Care Med Correspondence American Thoracic Society 2022-05-18 /pmc/articles/PMC9716918/ /pubmed/35584340 http://dx.doi.org/10.1164/rccm.202205-0835LE Text en Copyright © 2022 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern (dgern@thoracic.org). |
spellingShingle | Correspondence Molyneaux, Philip L. Maher, Toby M. Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice |
title | Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice |
title_full | Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice |
title_fullStr | Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice |
title_full_unstemmed | Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice |
title_short | Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice |
title_sort | reply to fujimoto et al.: the need for a cyfra 21-1 cutoff value to predict clinical progression of ipf in clinical practice |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716918/ https://www.ncbi.nlm.nih.gov/pubmed/35584340 http://dx.doi.org/10.1164/rccm.202205-0835LE |
work_keys_str_mv | AT molyneauxphilipl replytofujimotoetaltheneedforacyfra211cutoffvaluetopredictclinicalprogressionofipfinclinicalpractice AT mahertobym replytofujimotoetaltheneedforacyfra211cutoffvaluetopredictclinicalprogressionofipfinclinicalpractice |